MeiraGTx Holdings (MGTX) Tax Rate (2018 - 2026)
MeiraGTx Holdings' (MGTX) quarterly Tax Rate came in at 69.27% in Q4 2019, down 7148.0% YoY from 0.98% in Q4 2018, and down 2309.03% on a QoQ basis from 3.14% in Q3 2019.
Powered by 
Analysis
MeiraGTx Holdings (MGTX) Tax Rate (2018 - 2026) Analysis & Trends
MeiraGTx Holdings (MGTX) has 2 years of Tax Rate data on file, last reported at 69.27% in Q4 2019.
- Quarterly Tax Rate fell 7148.0% year-over-year to 69.27% in Q4 2019, while the trailing twelve-month figure through Dec 2019 was 4.5% (changed N/A YoY) and the FY2019 annual result came in at 5.61%, down 618.0% from the prior year.
- Tax Rate declined to 69.27% in Q4 2019, from 3.14% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 3.14% in Q3 2019 to a low of 69.27% in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | 0.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.98% |
| Dec 31, 2019 | 197.42% |
| Sep 30, 2019 | 3.14% |
| Jun 30, 2019 | 0.44% |
| Dec 31, 2018 | 2.20% |